Hamzah Syed
机构:Türkisch-Deutsche Universität · ORCID:0000-0001-6981-6962
发表论文 34 篇 · 总被引 132 次 · h-index 7
代表论文
- Exploiting epigenetic targets to overcome taxane resistance in prostate cancer (2024 · Cell Death and Disease · 被引 21)
- EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities (2022 · Cell Death and Disease · 被引 21)
- Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival (2023 · Cell Communication and Signaling · 被引 13)
- The use of class imbalanced learning methods on ULSAM data to predict the case–control status in genome-wide association studies (2023 · Journal Of Big Data · 被引 7)
- Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer (2025 · Experimental & Molecular Medicine · 被引 5)
- The Use of Class Imbalanced Learning Methods on ULSAM Data to Predict the Case-Control Status in Genome-Wide Association Studies (2023 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 4)